➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Merck
Mallinckrodt
Moodys
Harvard Business School
Dow
Colorcon

Last Updated: October 26, 2021

DrugPatentWatch Database Preview

Accord Hlthcare Company Profile


Email this page to a colleague

« Back to Dashboard

What is the competitive landscape for ACCORD HLTHCARE, and what generic and branded alternatives to ACCORD HLTHCARE drugs are available?

ACCORD HLTHCARE has one hundred and thirty-two approved drugs.

There are ten tentative approvals on ACCORD HLTHCARE drugs.

Summary for Accord Hlthcare
US Patents:0
Tradenames:116
Ingredients:113
NDAs:132

Drugs and US Patents for Accord Hlthcare

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Accord Hlthcare ROPINIROLE HYDROCHLORIDE ropinirole hydrochloride TABLET;ORAL 204022-006 Feb 28, 2017 AB RX No No ⤷  Free Forever Trial ⤷  Free Forever Trial
Accord Hlthcare CINACALCET HYDROCHLORIDE cinacalcet hydrochloride TABLET;ORAL 211892-002 May 15, 2020 AB RX No No ⤷  Free Forever Trial ⤷  Free Forever Trial
Accord Hlthcare LEVOTHYROXINE SODIUM levothyroxine sodium TABLET;ORAL 212399-004 Oct 19, 2020 AB2 RX No No ⤷  Free Forever Trial ⤷  Free Forever Trial
Accord Hlthcare CISATRACURIUM BESYLATE cisatracurium besylate INJECTABLE;INJECTION 205873-001 Jun 16, 2017 DISCN No No ⤷  Free Forever Trial ⤷  Free Forever Trial
Accord Hlthcare TACROLIMUS tacrolimus OINTMENT;TOPICAL 211688-001 Jan 31, 2019 AB RX No No ⤷  Free Forever Trial ⤷  Free Forever Trial
Accord Hlthcare ROPINIROLE HYDROCHLORIDE ropinirole hydrochloride TABLET;ORAL 204022-002 Feb 28, 2017 AB RX No No ⤷  Free Forever Trial ⤷  Free Forever Trial
Accord Hlthcare ISOSORBIDE MONONITRATE isosorbide mononitrate TABLET, EXTENDED RELEASE;ORAL 209684-003 Oct 24, 2017 DISCN No No ⤷  Free Forever Trial ⤷  Free Forever Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Paragraph IV (Patent) Challenges for ACCORD HLTHCARE drugs
Drugname Dosage Strength Tradename Submissiondate
➤ Subscribe for Injection 100 mcg/vial and 500 mcg/vial ➤ Subscribe 2015-04-14
➤ Subscribe for Injection 200 mcg/vial ➤ Subscribe 2015-05-01
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Boehringer Ingelheim
Colorcon
Express Scripts
McKesson
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.